Senate LDA lobbying filing

ABBOTT LABORATORIES

Registrant: W STRATEGIES, LLC Year: 2024 Period: First Quarter Type: Q1

View on lda.senate.gov ↗

Reported income

$50.0K

Reported expenses

not reported

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

AAV7A1 PIP2021matched: “2021”PE code cited directly
Issues related to UNOS and heart transplant criteria. H.R.4128: VALID Act of 2021. H.R.7213 - Equitable Community…

Lobbying activities1

Health IssuesHCR
Issues related to UNOS and heart transplant criteria. H.R.4128: VALID Act of 2021. H.R.7213 - Equitable Community Access to Pharmacist Services Act. SUPPORT Act reauthorization.

Lobbyists1

DARREN WILLCOX

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.